Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): A cross-sectional cohort study

Clinical Endocrinology

Volumn 79, Issue 5, 2013, Pages 641-647

  Schreiver, C ^a   Jacoby, U ^a   Watzer, B ^b   Thomas, A ^c   Haffner, D ^a,d   Fischer, D C ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Medtronic GmbH   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PROSTAGLANDIN F2; PROSTAGLANDIN SYNTHASE;

ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, SUBCUTANEOUS; INJECTIONS; INSULIN; INSULIN INFUSION SYSTEMS; MALE;

EID: 84885200173     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12093     Document Type: Article

References (28)

1. Libby, P., Nathan, D.M., Abraham, K., et al,. (2005) Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation, 111, 3489-3493.
2. Giannini, C., Mohn, A., Chiarelli, F., et al,. (2011) Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev, 27, 436-460.
3. Schalkwijk, C.G., &, Stehouwer, C.D., (2005) Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond), 109, 143-159.
4. Brownlee, M., (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 54, 1615-1625.
5. Colette, C., &, Monnier, L., (2007) Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes. Hormone and Metabolic Research, 39, 683-686.
6. Schweer, H., Watzer, B., Seyberth, H.W., et al,. (1997) Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. Journal of Mass Spectrometry, 32, 1362-1370.
7. Danne, T., Lange, K., &, Kordonouri, O., (2008) Real-time glucose sensors in children and adolescents with type-1 diabetes. Hormone Research, 70, 193-202.
8. Tamborlane, W.V., Beck, R.W., Bode, B.W., et al,. (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. New England Journal of Medicine, 359, 1464-1476.
9. Schwartz, G.J., Muñoz, A., Schneider, M.F., et al,. (2009) New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology, 20, 629-637.
10. Kromeyer-Hauschild, K., Wabitsch, M., Kunze, D., et al,. (2001) Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderh, 149, 807-818.
11. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114, 555-576.
12. Schweer, H., Watzer, B., &, Seyberth, H.W., (1994) Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. Journal of Chromatography, 652, 221-227.
13. McDonnell, C.M., Donath, S.M., Vidmar, S.I., et al,. (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther, 7, 253-263.
14. Wentholt, I.M., Kulik, W., Michels, R.P., et al,. (2008) Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia, 51, 183-190.
15. Thomas, A., Schonauer, M., Achermann, F., et al,. (2009) The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. Diabetes Technol Ther, 11, 399-409.
16. Hanas, R., &, Adolfsson, P., (2006) Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatric diabetes, 7, 25-31.
17. Jeitler, K., Horvath, K., Berghold, A., et al,. (2008) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia, 51, 941-951.
18. Derosa, G., Maffioli, P., D'Angelo, A., et al,. (2009) Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI). Endocrine Journal, 56, 571-578.
19. Fatourechi, M.M., Kudva, Y.C., Murad, M.H., et al,. (2009) Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. Journal of Clinical Endocrinology and Metabolism, 94, 729-740.
20. Jakisch, B.I., Wagner, V.M., Heidtmann, B., et al,. (2008) Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabetic Medicine, 25, 80-85.
21. Karagianni, P., Sampanis, C., Katsoulis, C., et al,. (2009) Continuous subcutaneous insulin infusion versus multiple daily injections. Hippokratia, 13, 93-96.
22. Monami, M., Lamanna, C., Marchionni, N., et al,. (2010) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetologica, 47, 77-81.
23. Weissberg-Benchell, J., Antisdel-Lomaglio, J., &, Seshadri, R., (2003) Insulin pump therapy: a meta-analysis. Diabetes Care, 26, 1079-1087.
24. Mastrototaro, J., Shin, J., Marcus, A., et al,. (2008) The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther, 10, 385-390.
25. Clarke, W., &, Kovatchev, B., (2009) Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther, 11 (Suppl 1), S45-54.
26. Rodbard, D., (2009) Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther, 11 (Suppl 1), S55-67.
27. Lepore, G., Corsi, A., Dodesini, A.R., et al,. (2010) Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control. Diabetes Care, 33, e81.
28. Monnier, L., Mas, E., Ginet, C., et al,. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295, 1681-1687.